Published by Iain Gilbert on 14th May 2018
(Sharecast News) - Blood disease-focused biotechnology company Hemogenyx Pharmaceuticals will receive support in the research, development and marketing of new drugs in return for licensing out the resulting product to the unnamed new partner.
URL: http://www.digitallook.com/dl/news/story/27462168/...